DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,157,788 | +3.7% | 4,667 | +0.3% | 0.45% | +10.0% |
| Q2 2023 | $1,116,845 | -5.1% | 4,654 | -0.3% | 0.41% | -8.3% |
| Q1 2023 | $1,176,628 | -5.0% | 4,668 | 0.0% | 0.45% | -8.2% |
| Q4 2022 | $1,239,069 | +0.6% | 4,668 | -2.1% | 0.49% | -6.7% |
| Q3 2022 | $1,232,000 | -7.4% | 4,768 | -9.1% | 0.52% | -0.8% |
| Q2 2022 | $1,330,000 | -13.6% | 5,247 | 0.0% | 0.53% | +0.6% |
| Q1 2022 | $1,540,000 | -10.8% | 5,247 | 0.0% | 0.52% | -6.8% |
| Q4 2021 | $1,726,000 | -1.4% | 5,247 | -8.7% | 0.56% | -5.6% |
| Q3 2021 | $1,750,000 | +14.5% | 5,747 | +0.9% | 0.59% | +12.7% |
| Q2 2021 | $1,528,000 | +19.2% | 5,694 | 0.0% | 0.53% | +16.1% |
| Q1 2021 | $1,282,000 | +1.3% | 5,694 | 0.0% | 0.45% | -0.9% |
| Q4 2020 | $1,265,000 | +3.2% | 5,694 | 0.0% | 0.46% | -5.8% |
| Q3 2020 | $1,226,000 | +19.0% | 5,694 | -2.2% | 0.49% | +16.3% |
| Q2 2020 | $1,030,000 | -97.0% | 5,823 | -97.8% | 0.42% | -96.9% |
| Q1 2020 | $33,896,000 | +3200.5% | 263,188 | +3831.7% | 13.46% | +3306.3% |
| Q4 2019 | $1,027,000 | +6.2% | 6,694 | 0.0% | 0.40% | +7.6% |
| Q3 2019 | $967,000 | +0.3% | 6,694 | -0.7% | 0.37% | -13.4% |
| Q2 2019 | $964,000 | +8.3% | 6,744 | 0.0% | 0.42% | +8.2% |
| Q1 2019 | $890,000 | +4.7% | 6,744 | -18.2% | 0.39% | +2.3% |
| Q4 2018 | $850,000 | -5.1% | 8,244 | 0.0% | 0.38% | +42.9% |
| Q3 2018 | $896,000 | +10.1% | 8,244 | 0.0% | 0.27% | -23.4% |
| Q2 2018 | $814,000 | +0.9% | 8,244 | 0.0% | 0.35% | +0.3% |
| Q1 2018 | $807,000 | +5.5% | 8,244 | 0.0% | 0.35% | +8.7% |
| Q4 2017 | $765,000 | +10.2% | 8,244 | +1.9% | 0.32% | +0.3% |
| Q3 2017 | $694,000 | -0.6% | 8,094 | -2.2% | 0.32% | -8.8% |
| Q2 2017 | $698,000 | -1.4% | 8,276 | 0.0% | 0.35% | -4.4% |
| Q1 2017 | $708,000 | -0.3% | 8,276 | -9.3% | 0.37% | -2.9% |
| Q4 2016 | $710,000 | -0.6% | 9,126 | +0.2% | 0.38% | -4.1% |
| Q3 2016 | $714,000 | -17.8% | 9,106 | +5.8% | 0.39% | -18.6% |
| Q2 2016 | $869,000 | -9.2% | 8,606 | -14.7% | 0.48% | -11.8% |
| Q1 2016 | $957,000 | +6.3% | 10,090 | +4.1% | 0.55% | +4.8% |
| Q4 2015 | $900,000 | +12.9% | 9,690 | +3.6% | 0.52% | +6.3% |
| Q3 2015 | $797,000 | +11.5% | 9,356 | +12.0% | 0.49% | +18.8% |
| Q2 2015 | $715,000 | – | 8,356 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |